Why the Right Marketing Partner Makes All the Difference
I recently spoke with the frustrated CEO of a company developing a fluorescence-guided surgery platform to improve surgical precision. He lamented that his current agency just didn’t grasp the science. It’s virtually impossible to market something you don’t understand. Now more than ever, life sciences marketing requires a specialist approach. For life sciences companies, this disconnect can be costly.
I will give a real-world case: Pfizer’s Exubera inhaled insulin.
What happened: Clinically effective and FDA-approved as the first inhaled insulin, Exubera was a novel alternative to injections for diabetics. It was introduced in 2006.
What went wrong:
-
- Failed to differentiate the brand from well-established injectable alternatives.
- Sales materials didn’t equip reps to explain the novel mechanism to HCPs.
- Provider education efforts were insufficient, leaving key prescribers uncertain or unaware of clinical value.
- Device design and size created negative perceptions that weren’t effectively managed through messaging.
- Payer strategy lacked clarity, leading to confusion around reimbursement and resistance to premium pricing.
Result: Withdrawn from market in 2007 after $2.8B investment and underwhelming sales.
Beyond the scientific and regulatory hurdles, life sciences innovators must take steps to enhance the likelihood that their breakthroughs are understood, trusted, and adopted. Whether you’re developing a breakthrough diagnostic, a novel therapeutic, or a digital health platform, your story will only matter if it’s told in the right way to the right people.
This is precisely why life sciences marketing is not a job for generalists.
Science-Driven Messaging Needs More Than Just Creativity
Marketing in life sciences isn’t about splashy ads or flashy slogans; it’s about accuracy, credibility, and connection. You are speaking to clinicians, payers, investors, regulators, and even patients. The trick is that you will not talk with a clinician in the same way as an investor or a consumer. All of them expect scientific fluency and strategic relevance, but the message is different. Miscommunication isn’t just a missed opportunity; it can be a risk to your brand or a delay in adoption.
I have found that the best marketing starts with understanding the “why” behind the innovation. It forms the basis of a unique value proposition. Why should someone buy a new diagnostic test? Is it more sensitive, specific, safer, easier to administer, or saves money? If the answer is none of the above, it probably would not be reimbursable and would fail in the market. Since most of these unique salable properties are technical, we lead with science. Our background in gene therapy, cancer research, and diagnostics allows us to translate complex mechanisms into clear, confident narratives while maintaining scientific rigor. How compelling that message is depends on who you are speaking to. This is where our extensive marketing and sales experience comes into play.
Why a Specialist Marketing Partner Matters
Too often, life sciences leaders tell us they feel let down by their marketing agency. The problem? The agency doesn’t understand the science.
When that happens, your differentiation gets watered down, clinical evidence gets misrepresented, and you lose ground with critical stakeholders.
Conversely, a specialist agency brings:
-
- Deep scientific understanding of your product that ensures technical accuracy which builds trust
- Ability to differentiate your product from competitive alternatives
- Experience with regulatory standards that helps avoid compliance missteps
- Tailored go-to-market (GTM) strategies that speak to specific target audiences in their language
- Faster ramp-up because no translation of science is needed between collaborating inventors and agency teams
The right agency partner does more than execute; they bring a fresh perspective. They think with you, and often make you consider angles, audiences, or opportunities you may have missed.
A Strategic Extension of Your Team
If you are experiencing headwinds in the market, choosing the right partner is a strategic priority. A specialized firm becomes more than hired hands. It will act as an extension of your marketing team, helping shape GTM plans, sharpen positioning, and communicate in ways that influence both clinical and commercial performance.
This is especially critical in a world where the B2B buyers desire content that resonates both internally and externally. They want a partner who can arm their champions with the right tools.
Final Thought
You’ve invested time, talent, and capital into something that could change lives. Don’t risk falling short at the last mile because your message gets lost in translation. Partner with people who understand your science and get it noticed and drive adoption.
Need a team that can speak both molecule and market? Let’s talk.
By Brad Saeed, MS, MBA, Founder, President, & Lead Strategist
Brad is the founder and president of BTS Consulting, a life sciences strategy and marketing firm he launched in 2009 to solve a gap he experienced firsthand. As a former decision science project leader, he saw that most external support teams were either fluent in science or strong in marketing, but rarely both. With a background in molecular and cell biology and formal training in business strategy, Brad set out to bridge the divide between scientific innovation and effective market execution.
With over 20 years of industry experience, he began his career at the bench and has since led high-impact initiatives across pharmaceuticals, diagnostics, medical devices, and healthcare services. Brad is a seasoned strategist and science-driven content developer known for driving market acceptance of complex technologies. He is also a skilled grant writer and a respected voice at the intersection of science, strategy, and commercialization.

